Fresenius SE KGaA (XTER:FRE) LT-Debt-to-Total-Asset : 0.29 (As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Fresenius SE KGaA LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Fresenius SE KGaA's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.29.

Fresenius SE KGaA's long-term debt to total assets ratio declined from Dec. 2022 (0.32) to Dec. 2023 (0.29). It may suggest that Fresenius SE KGaA is progressively becoming less dependent on debt to grow their business.

Fresenius SE KGaA LT-Debt-to-Total-Asset Historical Data

The historical data trend for Fresenius SE KGaA's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA LT-Debt-to-Total-Asset Chart

Fresenius SE KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.33

0.31

0.32

0.29

Fresenius SE KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.32	0.30	0.30	0.17	0.29

Fresenius SE KGaA LT-Debt-to-Total-Asset Calculation

Fresenius SE KGaA's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	13249	/	45284
	=	0.29

Fresenius SE KGaA's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	13249	/	45284
	=	0.29

Fresenius SE KGaA (XTER:FRE) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Fresenius SE KGaA LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresenius SE KGaA (XTER:FRE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (XTER:FRE) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

FSNUY:USA FSNUF:USA FREN:Mexico FRE:Italy FREd:UK 0OO9:UK FRE:Austria

Address

Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.fresenius.com

Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Executives

Dr. Michael Moser	Board of Directors
Sara Hennicken	Board of Directors
Michael Sen	Board of Directors
Dr. Francesco De Meo	Board of Directors
Stephan Sturm	Board of Directors
Wolfgang Kirsch	Supervisory Board
Mats Henriksson	Board of Directors
Dr. Gerd Krick	Supervisory Board

Fresenius SE KGaA (XTER:FRE) Headlines

No Headlines